Tuya Mungun, Mongolia
Ministry of Health National Centre for Communicable DiseaseAuthor Of 5 Presentations
DETERMINING THE PNEUMOCOCCAL CONJUGATE VACCINE COVERAGE REQUIRED FOR INDIRECT PROTECTION IN LAOS, MONGOLIA AND PAPUA NEW GUINEA (ID 851)
- Jocelyn Chan,
- Cattram D. Nguyen, Australia
- Eileen M. Dunne, United States of America
- Christopher C. Blyth, Australia
- David A. Dance, Laos
- Rebecca Ford, Papua New Guinea
- Jana Y. Lai, Australia
- Sophie La Vincente, Australia
- Deborah Lehmann, Australia
- Siddhartha S. Datta, Laos
- Kimberley Fox, Philippines
- Monica L. Nation, Australia
- Jason Hinds, United Kingdom
- Tuya Mungun, Mongolia
- Paul N. Newton, United Kingdom
- William Pomat, Papua New Guinea
- Keoudomphone Vilivong, Laos
- Claire Von Mollendorf, Australia
- Anonh Xeuatvongsa, Laos
- Catherine Satzke, Australia
- Kim E. Mulholland, Australia
- Fiona M. Russell, Australia
MONITORING PCV13 IMPACT USING NASOPHARYNGEAL CARRIAGE SURVEILLANCE AMONG CHILDREN WITH PNEUMONIA IN MONGOLIA (ID 965)
- Purevsuren Batsaikhan, Mongolia
- Jocelyn Chan,
- Tuya Mungun, Mongolia
- Eileen M. Dunne, United States of America
- Sophie La Vincente, Australia
- Dorj Narangerel, Mongolia
- Monica L. Nation, Australia
- J Hinds,
- Cattram D. Nguyen, Australia
- Mukhchuluun Ulziibayar, Mongolia
- Catherine Satzke, Australia
- Kim E. Mulholland, Australia
- Claire Von Mollendorf, Australia
- Fiona M. Russell, Australia
Abstract
Background
In 2015, Mongolia was among the earliest countries in Asia to introduce PCV. To monitor the impact of PCV13 introduction, we commenced nasopharyngeal carriage surveillance among children with pneumonia 6 months prior to vaccine introduction.
Methods
We recruited children 2-59 months of age presenting with pneumonia to district hospitals and the national Maternal and Child Health hospital in two districts in Ulaanbaatar. Clinical and demographic data, vaccination status and nasopharyngeal swabs were collected. A random sample of swabs were selected for testing each month. Samples were examined by lytA qPCR, with positives serotyped by microarray.
Results
We recruited 4980 children and tested 983 children from November 2015 to April 2018. The median age was 1.27 and 25.81% of cases were vaccinated in the first and second year following PCV13 introduction, respectively. 474 and 48.22% had received antibiotics in the 48 hours before admission.
Conclusions
Following PCV13 introduction in Mongolia, the prevalence of pneumococcal carriage remained stable while the prevalence of PCV13-type carriage decreased among children with pneumonia. Reductions in PCV13 carriage likely correspond to reductions in disease due to PCV13 types, since carriage is a precursor for disease.
PNEUMOCOCCAL CARRIAGE IN CHILDREN WITH PNEUMONIA IN THREE ASIAN COUNTRIES FOLLOWING VACCINE INTRODUCTION (ID 1082)
- Catherine Satzke, Australia
- Eileen M. Dunne, United States of America
- Jocelyn Chan,
- Monica L. Nation, Australia
- Keoudomphone Vilivong, Laos
- Belinda D. Ortika, Australia
- Mimee Laddaphone, Laos
- Rebecca Ford, Papua New Guinea
- Joycelyn J. Sapura, Papua New Guinea
- John Kave, Papua New Guinea
- Cattram D. Nguyen, Australia
- Casey L. Pell, Australia
- Ahmed Alamrousi, Australia
- Jason Hinds, United Kingdom
- Paul N. Newton, United Kingdom
- Anonh Xeuatvongsa, Laos
- B Bunjinlham,
- Christopher C. Blyth, Australia
- David A. Dance, Laos
- William Pomat, Papua New Guinea
- Claire Von Mollendorf, Australia
- Tuya Mungun, Mongolia
- Kim E. Mulholland, Australia
- Fiona M. Russell, Australia
PNEUMOCOCCAL CARRIAGE AND DENSITY IN MONGOLIAN CHILDREN WITH RADIOLOGICALLY-CONFIRMED PNEUMONIA AND HEALTHY CHILDREN FROM THE COMMUNITY. (ID 387)
- Monica L. Nation, Australia
- Cattram D. Nguyen, Australia
- Eileen M. Dunne, United States of America
- Casey L. Pell, Australia
- Jason Hinds, United Kingdom
- Mukhchuluun Ulziibayar, Mongolia
- Bujinlkham Suuri, Mongolia
- Dashtseren Luvsantseren, Mongolia
- Tuya Mungun, Mongolia
- Kim E. Mulholland, Australia
- Claire Von Mollendorf, Australia
- Catherine Satzke, Australia
A DYNAMIC MODEL TO DETERMINE FACTORS REQUIRED FOR ELIMINATION OF VACCINE-TYPE CARRIAGE FOLLOWING PNEUMOCOCCAL CONJUGATE VACCINE INTRODUCTION IN THE ASIA-PACIFIC (ID 850)
- Jocelyn Chan,
- Virginia Pitzer, United States of America
- Cattram D. Nguyen, Australia
- Eileen M. Dunne, United States of America
- Christopher C. Blyth, Australia
- David A. Dance, Laos
- Rebecca Ford, Papua New Guinea
- Jana Y. Lai, Australia
- Sophie La Vincente, Australia
- Deborah Lehmann, Australia
- Siddhartha S. Datta, Laos
- Kimberley Fox, Philippines
- Monica L. Nation, Australia
- Jason Hinds, United Kingdom
- Tuya Mungun, Mongolia
- Paul N. Newton, United Kingdom
- William Pomat, Papua New Guinea
- Keoudomphone Vilivong, Laos
- Claire Von Mollendorf, Australia
- Anonh Xeuatvongsa, Laos
- Catherine Satzke, Australia
- Kim E. Mulholland, Australia
- Daniel M. Weinberger, United States of America
- Fiona M. Russell, Australia